Featured Research

from universities, journals, and other organizations

Analysis Of Tuberculosis Treatment Studies Identifies Gaps In Guidelines

Date:
September 14, 2009
Source:
Public Library of Science
Summary:
International guidelines for treating tuberculosis are due for specific improvements, according to two new research papers.

International guidelines for treating tuberculosis are due for specific improvements, according to two research papers published this week in the open access journal PLoS Medicine.

Related Articles


Public health programs in many countries adhere to World Health Organization (WHO) guidelines as the authoritative recommendations for treating tuberculosis (TB). But do these guidelines reflect the best available evidence? To answer this question, Dick Menzies of McGill University in Montreal and colleagues reviewed all available results from trials of currently recommended treatment regimens, first for initial treatment of TB, and then for individuals who had been previously treated without being cured, or had infections that were resistant to isoniazid, one of the main first-line anti-TB drugs.

In the first study, the researchers identified and analyzed 57 randomized, controlled clinical trials including more than 20,000 participants treated for TB. They found that regimens utilizing the drug rifampin for only the first 2 months, which have been recommended in 24 countries with high rates of TB infection, had significantly higher rates of failure, relapse, and acquired drug resistance compared with regimens that used rifampin for at least 6 months.

The second study analyzed trials of TB treatment in previously treated individuals, or those with isoniazid-resistant infection. The researchers found no randomized trials comparing the currently recommended WHO retreatment regimen against other approaches. In non-comparative (cohort) studies, failure rates were generally low if participants were infected with strains that were sensitive to all antibiotics in the regimen. However, in studies in which participants were infected with a strain of Mycobacterium tuberculosis resistant to one or more drugs, failure rates ranged from 9% to 45%.

The researchers also analyzed the combined results of 33 trials that investigated the effect of various regimens on almost 2,000 patients (some receiving their first treatment for TB, others being retreated) with resistance to isoniazid alone. This meta-analysis found lower relapse, failure and acquired drug resistance rates to be associated with longer duration of rifampin treatment, daily therapy early in treatment, inclusion of the drug streptomycin, and regimens that included a greater number of drugs to which the patient's TB infection was sensitive.

Taken together, these findings will inform upcoming revisions of the WHO TB treatment guidelines, and identify an important need for clinical trials to evaluate dosing schedules, detection and management of isoniazid resistance, and the optimal duration of treatment to prevent relapse, as well as more effective approaches to retreatment of tuberculosis.


Story Source:

The above story is based on materials provided by Public Library of Science. Note: Materials may be edited for content and length.


Journal References:

  1. Menzies D, Benedetti A, Paydar A, Martin I, Royce S, et al. Effect of Duration and Intermittency of Rifampin on Tuberculosis Treatment Outcomes: A Systematic Review and Meta-Analysis. PLoS Medicine, 2009; 6 (9): e1000146 DOI: 10.1371/journal.pmed.1000146
  2. Menzies D, Benedetti A, Paydar A, Royce S, Pai M, et al. Standardized Treatment of Active Tuberculosis in Patients with Previous Treatment and/or with Mono-resistance to Isoniazid: A Systematic Review and Meta-analysis. PLoS Medicine, 2009; 6 (9): e1000150 DOI: 10.1371/journal.pmed.1000150

Cite This Page:

Public Library of Science. "Analysis Of Tuberculosis Treatment Studies Identifies Gaps In Guidelines." ScienceDaily. ScienceDaily, 14 September 2009. <www.sciencedaily.com/releases/2009/09/090914202134.htm>.
Public Library of Science. (2009, September 14). Analysis Of Tuberculosis Treatment Studies Identifies Gaps In Guidelines. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2009/09/090914202134.htm
Public Library of Science. "Analysis Of Tuberculosis Treatment Studies Identifies Gaps In Guidelines." ScienceDaily. www.sciencedaily.com/releases/2009/09/090914202134.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins